info@seagull-health.com
SeagullHealth
语言:
search

Qlosi(Pilocarpine HCl ophthalmic solution 0.4%)

Names
盐酸毛果芸香碱滴眼液
Indicatons
Treatment of presbyopia in adults.
Price:
Manufacturer:
Orasis
Dosage form:
SOLUTION
Validity period:
24 months

Reminder: The outer packaging is for reference only, please purchase and use under the guidance of a pharmacist. For read by medical and pharmaceutical professionals only.

Qlosi(Pilocarpine HCl ophthalmic solution 0.4%) Instructions:Uses,Dosage, Side Effects

QLOSI is a sterile, slightly viscous ophthalmic solution with a strength of 0.4% pilocarpine hydrochloride (equivalent to 4 mg/mL). It is supplied in single-patient-use vials and functions as a cholinergic agonist targeting muscarinic receptors to improve near vision. Manufactured by Orasis Pharmaceuticals, it is stored refrigerated and discarded after each use.

Generic name
Qlosi(Pilocarpine HCl ophthalmic solution 0.4%)
English name
Pilocarpine HCl ophthalmic solution 0.4%
Alternative Names
盐酸毛果芸香碱滴眼液
Drug prices
Indications

QLOSI is indicated for the treatment of presbyopia in adult patients.

Therapeutic Target
Muscarinic cholinergic receptors located in the iris sphincter and ciliary muscles.
Active Ingredients
Pilocarpine hydrochloride
Dosage Form
SOLUTION
Specifications
Dosage and Administration

Instill one drop in each eye. A second drop may be administered after 2–3 hours for extended effect (up to 8 hours). May be used daily or as needed, up to twice daily. If using other topical ophthalmic agents, allow at least 5 minutes between applications. Discard vial after single use.

    Recommended articles
    Related articles
    How to Use Qlosi Eye Drops
    Qlosi Eye Drops is a cholinergic agonist used for the treatment of presbyopia in adults.How to Use Qlosi Eye DropsRoutine UsageSingle Dose: Instill 1 drop of Qlosi into each eye. The maximum frequency...
    Precautions for the Use of Qlosi Eye Drops
    Qlosi Eye Drops is a cholinergic agonist indicated for the treatment of presbyopia in adults.Precautions for the Use of Qlosi Eye DropsContraindicationsPatients with a known allergy to the active ingr...
    New Drugs
    Infigratinib(Truseltiq)
    Infigratinib(Truseltiq)
    Treatment of previously treated, unresectable locally advanced or metastatic...
    Opicapone(Ongentys)
    Opicapone(Ongentys)
    Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
    Deflazacort(Emflaza)
    Deflazacort(Emflaza)
    Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
    Faricimab-svoa(Vabysmo)
    Faricimab-svoa(Vabysmo)
    Treatment of neovascular age-related macular degeneration, diabetic macular...
    Counselling Service
    Global Drug Search
    Clinical Research Recruitment
    Overseas Medical Treatment
    Remote Consultations
    Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
    Submit
    Business
    • Core products
    • Antitumor drugs
    • General drug
    • Antiviral drugs
    • Biological agents
    Contact Us 
    • mailbox:info@lucius.la
    Welcome to consult
    ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved